Change to advertising rules horrifies critics
A government plan to scrap pre-approval of advertisements for TGA-listed medicines has been greeted with horror, with critics saying it will open the floodgates of crazy claims plastered on billboards and TV.
At the moment any advertising for a listed therapeutic product must be pre-approved by the two industry peak bodies.
But on Thursday the federal government announced it will scrap this system and replace it with an-as yet unspecified “self-regulation regime”.
The reform was one of 58 recommendations in a review of medicines and devices regulation led by Emeritus Professor Lloyd Sansom.
The government says it will “help reduce unnecessary complexity for sponsors and advertisers”.